Neumann Advisory Hong Kong Ltd

Fundamental concentrated ★Highest signal industrials specialist (76%) CIK 1727862
League rank
#105
in Fundamental concentrated · #166 overall
Long book
$317.5M
Q1 2026
Positions
6
Top-10 weight
100%
concentration
Last quarter
+8.5%
SPY +14.8%
Turnover
14%
of book per quarter

Strategy in plain words

auto-generated from filings

Neumann Advisory Hong Kong Ltd is a concentrated fundamental stock-picker, specialised in industrials (76% of the long book), running a $317.5M US long book across 6 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is modest: positions are typically held for years. Current anchor positions: TESLA INC, ALPHABET INC-CL A, META PLATFORMS INC-CLASS A, AGORA INC-ADR, SINOVAC BIOTECH LTD.

Over the last 9 quarters its long book ran on average 6pp per quarter ahead of the S&P 500, beating the index in 5 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
+7.5%
Q2 2024
+20.0%
Q3 2024
+47.1%
Q4 2024
-31.8%
Q1 2025
+24.3%
Q2 2025
+34.0%
Q3 2025
+0.3%
Q4 2025
-15.7%
Q1 2026
+8.5%

Sector allocation

Industrials
77%
Technology
22%
Healthcare
1%

Long book by quarter

$203.7M
Q1 2024
$210.0M
Q2 2024
$247.1M
Q3 2024
$341.0M
Q4 2024
$232.7M
Q1 2025
$280.2M
Q2 2025
$393.4M
Q3 2025
$377.8M
Q4 2025
$317.5M
Q1 2026

What does Neumann Advisory own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
TSLA TESLA INCIndustrials649.8K$241.6M76.1%Held
GOOGL ALPHABET INC-CL ATechnology160.7K$46.2M14.6%+4.3%
META META PLATFORMS INC-CLASS ATechnology38.5K$22.0M6.9%Held
SVA SINOVAC BIOTECH LTDHealthcare315.6K$2.0M0.6%Held
ESTC ELASTIC NVTechnology35.9K$1.8M0.6%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRApr 14, 20266$317.5M $K fixed canonicalSEC ↗
Q4 202513F-HRJan 8, 20267$2.82B $K fixed canonicalSEC ↗
Q3 202513F-HROct 8, 20258$393.4M $K fixed canonicalSEC ↗
Q2 202513F-HRJul 7, 20259$280.2M $K fixed canonicalSEC ↗
Q1 202513F-HRApr 8, 202510$232.7M $K fixed canonicalSEC ↗
Q4 202413F-HRJan 22, 202510$341.0M $K fixed canonicalSEC ↗
Q3 202413F-HROct 8, 202412$247.1M $K fixed canonicalSEC ↗
Q2 202413F-HRJul 10, 202414$210.0M $K fixed canonicalSEC ↗
Q1 202413F-HRApr 12, 202415$203.7M $K fixed canonicalSEC ↗